Serum Institute dismissed the participant's allegation as "malicious and misconceived". - Reuters
KOCHI (The Straits Times/ANN): Serum Institute of India has threatened to file a defamation suit against a participant who reported having adverse reactions after receiving a dose of the company's test Covid-19 vaccine during the clinical trial in India.
An official at the Indian Council of Medical Research (ICMR), a co-sponsor of the vaccine trial along with Serum Institute, said that the Drug Controller General of India (DCGI) is inquiring into whether the volunteer's illness is linked to the vaccine under study.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
